Novartis has entered into an agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts focused on developing novel radioligand therapies...
Repertoire Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell targeted immune medicines, has entered a multi-year strategic collaboration...
Regeneron Pharmaceuticals and Mammoth Biosciences have formed a collaboration to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and...